Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?

被引:174
作者
Kupari, M [1 ]
Turto, H [1 ]
Lommi, J [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Cardiol, Helsinki 00029, Finland
关键词
aortic valve stenosis; heart failure; left ventricular hypertrophy;
D O I
10.1093/eurheartj/ehi290
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims In aortic stenosis (AS), left ventricular (LV) hypertrophy is considered a compensatory response helping maintain systolic function. Recent research in experimental AS suggests, however, that LV hypertrophy is not necessary to sustain LV contractions but may in fact be maladaptive. The present work aimed to clarify the role of LV hypertrophy in AS-related heart failure (HF) in man. Methods and results We studied 137 adult patients with isolated AS undergoing pre-operative echocardiography and cardiac catheterization. HF was diagnosed by the European criteria and LV hypertrophy by sex-specific limits of echocardiographic LV mass. The higher the LV mass was, the poorer was the LV ejection fraction (beta=-0.26, P < 0.001, linear regression) and the greater the likelihood of HF independent of the severity of AS (P < 0.001, logistic regression). In the subgroup of critical AS (valve area < 0.4 cm(2)/m(2), n=85), patients with absent LV hypertrophy (n=19) had better preserved ejection fraction (mean +/- SE, 64 +/- 3 vs. 57 +/- 2%, P=0.045) and less HF (16 vs. 48%, P=0.025) than patients with LV hypertrophy (n=66). Conclusion In isolated AS, increased LV mass predicts the presence of systolic dysfunction and HF independent of the severity of valvular obstruction. LV hypertrophy may be maladaptive rather than beneficial in AS in man.
引用
收藏
页码:1790 / 1796
页数:7
相关论文
共 40 条
  • [1] Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
    Antos, CL
    McKinsey, TA
    Frey, N
    Kutschke, W
    McAnally, J
    Shelton, JM
    Richardson, JA
    Hill, JA
    Olson, EN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) : 907 - 912
  • [2] GEOMETRIC CHANGES ALLOW NORMAL EJECTION FRACTION DESPITE DEPRESSED MYOCARDIAL SHORTENING IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY
    AURIGEMMA, GP
    SILVER, KH
    PRIEST, MA
    GAASCH, WH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (01) : 195 - 202
  • [3] Chronic NG-nitro-L-arginine methyl ester-induced hypertension -: Novel molecular adaptation to systolic load in absence of hypertrophy
    Bartunek, J
    Weinberg, EO
    Tajima, M
    Rohrbach, S
    Katz, SE
    Douglas, PS
    Lorell, BH
    [J]. CIRCULATION, 2000, 101 (04) : 423 - 429
  • [4] Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease)
    Bonow, RO
    Carabello, B
    de Leon, AC
    Edmunds, LH
    Fedderly, BJ
    Freed, MD
    Gaasch, WH
    McKay, CR
    Nishimura, RA
    O'Gara, PT
    O'Rourke, RA
    Rahimtoola, SH
    Ritchie, JL
    Cheitlin, MD
    Eagle, KA
    Gardner, TJ
    Garson, A
    Gibbons, RJ
    Russell, RO
    Ryan, TJ
    Smith, SC
    [J]. CIRCULATION, 1998, 98 (18) : 1949 - 1984
  • [5] PROGRESSION OF AORTIC-STENOSIS IN 394 PATIENTS - RELATION TO CHANGES IN MYOCARDIAL-VALVE AND MITRAL-VALVE DYSFUNCTION
    BRENER, SJ
    DUFFY, CI
    THOMAS, JD
    STEWART, WJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (02) : 305 - 310
  • [6] BLOCKADE OF THE RENIN-ANGIOTENSIN SYSTEM IN CARDIAC PRESSURE-OVERLOAD HYPERTROPHY IN RATS
    BRUCKSCHLEGEL, G
    HOLMER, SR
    JANDELEIT, K
    GRIMM, D
    MUDERS, F
    KROMER, EP
    RIEGGER, GAJ
    SCHUNKERT, H
    [J]. HYPERTENSION, 1995, 25 (02) : 250 - 259
  • [7] CANTERINANTONIN.F, 2003, HYPERTENSION, V41, P1268
  • [8] CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099
  • [9] Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic cardiac obstruction-pilot study of enalapril in aortic stenosis (SCOPE-AS)
    Chockalingam, A
    Venkatesan, S
    Subramaniam, T
    Jagannathan, V
    Elangovan, S
    Alagesan, R
    Gnanavelu, G
    Dorairajan, S
    Krishna, BP
    Chockalingam, V
    [J]. AMERICAN HEART JOURNAL, 2004, 147 (04) : 740+L1 - L8
  • [10] CLELAND JG, 1995, EUR HEART J, V16, P741